Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement?
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement?
Creator
Mondor, Hôpital
Duong, T
Bagot, M
Bouaziz, J
Cassius, C
Duong, Tu
Fiani, C
Frumholtz, L
Kahla, Ben
Mrad, M
Petit, A
Skayem, C
Zuelgaray, E
Source
Medline; PMC
abstract
In the context of COVID‐19 pandemic, teledermatology is being favored over in‐person consultation in order to avoid the possibility of virus transmission(1). In France, COVID‐19 wasn't known to cause cutaneous manifestations before April 6(th) 2020, when an alert about possible associated skin symptoms was raised to the general public and the professional social network(2–4). We aimed to assess the impact of alerting about COVID‐associated lesions on the activity of urgent teledermatology (TD) and the activity of dermatologic emergencies unit (DEU) of two university hospitals during this pandemic.
has issue date
2020-05-18
(
xsd:dateTime
)
bibo:doi
10.1111/jdv.16630
bibo:pmid
32422693
has license
no-cc
sha1sum (hex)
184f1709105a9590eaaa24bb4018c8e68bd6de38
schema:url
https://doi.org/10.1111/jdv.16630
resource representing a document's title
Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement?
has PubMed Central identifier
PMC7276807
has PubMed identifier
32422693
schema:publication
J Eur Acad Dermatol Venereol
resource representing a document's body
covid:184f1709105a9590eaaa24bb4018c8e68bd6de38#body_text
is
schema:about
of
named entity 'SUBSTITUTE'
named entity 'TELEDERMATOLOGY'
named entity 'COVID-19'
named entity 'cutaneous'
named entity 'morbilliform rash'
named entity 'teledermatology'
named entity 'dermatological'
named entity 'COVID-19'
named entity 'urticaria'
named entity 'cutaneous'
named entity 'primary care'
named entity 'virus'
named entity 'health-care professionals'
named entity 'COVID-19'
named entity 'teledermatology'
named entity 'COVID-19'
named entity 'store-and-forward'
named entity 'COVID-19 pandemic'
named entity 'COVID-19'
named entity 'dermatologists'
named entity 'vasculitic'
named entity 'France'
named entity 'dermatologists'
named entity 'teledermatology'
named entity 'teledermatology'
named entity '3/80'
named entity 'chilblains'
named entity 'cutaneous'
named entity 'professional social network'
named entity 'skin conditions'
named entity 'dermatologic'
named entity '3/80'
named entity 'teledermatology'
named entity 'skin lesions'
named entity 'cutaneous'
named entity 'virus'
named entity '6/80'
named entity 'wasn'
named entity 'pauci'
named entity 'dermatologic'
named entity 'dermatologists'
named entity 'Teledermatology'
named entity 'SUPPLEMENT'
named entity 'TITLE'
named entity 'lesions'
named entity 'Article'
named entity 'Teledermatology'
named entity 'cutaneous'
named entity 'COVID-19'
named entity 'ARTICLE'
named entity 'COVID-19'
named entity 'CUTANEOUS'
named entity 'LESIONS'
is
part of
of
In the context of COVID‐19 pandemic, teledermatology is being favored over in‐person consultation in order to avoid the possibility of virus transmission(1). In France, COVID‐19 wasn't known to cause cutaneous manifestations before April 6(th) 2020, when an alert about possible associated skin symptoms was raised to the general public and the professional social network(2–4). We aimed to assess the impact of alerting about COVID‐associated lesions on the activity of urgent teledermatology (TD) and the activity of dermatologic emergencies unit (DEU) of two university hospitals during this pandemic.
covid:184f1709105a9590eaaa24bb4018c8e68bd6de38#body_text
Teledermatology for COVID‐19 cutaneous lesions: substitute or supplement?
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software